MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ejca.2026.116679

Медицинская библиотека · European journal of cancer (Oxford, England : 1990) · 2026

MuTriM: A multiscale deep learning model integrating longitudinal radiomics and pathomic features for predicting recurrence and adjuvant radiation benefit in breast cancer.

Wang Xiangxue, Chen Liya, Sun Jingwen, Khalighi Sirvan, Dam Tanmoy, Maurya Himanshu, Pathak Tilak, Lu Cheng, Gandhi Shipra, Badve Sunil, Zhao Shen, Yang Wentao, Xu Jun, Madabhushi Anant, Song Bolin

СтатьяПеревод в очереди

Аннотация

PURPOSE: We present MuTriM, a multimodal deep learning model integrating DCE-MRI and whole-slide pathology to predict survival and radiation benefit in breast cancer.

PATIENTS AND

METHODS

MuTriM employs an attention-based cross-modal and cross-temporal fusion framework that concurrently integrates DCE-MRI radiomic features with pathomic features of cellular morphology on WSI. MuTriM was trained on the Fudan University Shanghai Cancer Center (FUSCC) cohort (N = 335) and externally tested on the TCGA cohort (N = 126) using matched DCE-MRI and WSI.

RESULTS

MuTriM was prognostic of recurrence-free survival (RFS) in a subtype-agnostic setting (HR = 5.26, 95% CI, 1.69-16.4, p = 0.004; C-index = 0.75), outperforming unimodal models based on DCE-MRI alone (C-index = 0.65) or WSI alone (C-index = 0.70). MuTriM was also prognostic among HER2 + (HR = 6.82, 95% CI, 1.08-43.2, p = 0.04) and ER+ populations (HR = 4.61, 95% CI, 1.25-17.1, p = 0.02). A high MuTriM score was associated with improved RFS (HR = 0.15, 95% CI 0.03-0.87; P = 0.03), whereas a low MuTriM score showed no significant benefit (HR = 4.06, 95% CI 0.05-31; P = 0.53) (interaction P = 0.04). Transcriptomic analyses revealed that high-risk tumors showed suppressed cytotoxic T-cell activity and enrichment of extracellular matrix remodeling, neutrophil degranulation, and neuronal signaling, consistent with immune evasion. Upregulation of NRXN1, GABRA3, KCNK3, and KLK12 was linked to worse survival, whereas SYNGR3 and CD207 were associated with favorable outcomes.

CONCLUSION

By unifying radiology, pathology, and transcriptomics, MuTriM provides an interpretable multimodal framework for breast cancer prognosis and treatment guidance.

Для цитирования: Wang Xiangxue, Chen Liya, Sun Jingwen, Khalighi Sirvan, Dam Tanmoy, Maurya Himanshu, Pathak Tilak, Lu Cheng, Gandhi Shipra, Badve Sunil, Zhao Shen, Yang Wentao, Xu Jun, Madabhushi Anant, Song Bolin. MuTriM: A multiscale deep learning model integrating longitudinal radiomics and pathomic features for predicting recurrence and adjuvant radiation benefit in breast cancer.. European journal of cancer (Oxford, England : 1990). 2026. DOI: 10.1016/j.ejca.2026.116679.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.